Literature DB >> 25605766

Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection.

Wasiulla Rafi1, Kamlesh Bhatt1, William C Gause2, Padmini Salgame3.   

Abstract

Previously we had reported that Nippostrongylus brasiliensis, a helminth with a lung migratory phase, affected host resistance against Mycobacterium tuberculosis infection through the induction of alternatively activated (M2) macrophages. Several helminth species do not have an obligatory lung migratory phase but establish chronic infections in the host that include potent immune downregulatory effects, in part mediated through induction of a FoxP3(+) T regulatory cell (Treg) response. Treg cells exhibit duality in their functions in host defense against M. tuberculosis infection since their depletion leads to enhanced priming of T cells in the lymph nodes and attendant improved control of M. tuberculosis infection, while their presence in the lung granuloma protects against excessive inflammation. Heligmosomoides polygyrus is a strictly murine enteric nematode that induces a strong FoxP3 Treg response in the host. Therefore, in this study we investigated whether host immunity to M. tuberculosis infection would be modulated in mice with chronic H. polygyrus infection. We report that neither primary nor memory immunity conferred by Mycobacterium bovis BCG vaccination was affected in mice with chronic enteric helminth infection, despite a systemic increase in FoxP3(+) T regulatory cells. The findings indicate that anti-M. tuberculosis immunity is not similarly affected by all helminth species and highlight the need to consider this inequality in human coinfection studies.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605766      PMCID: PMC4333454          DOI: 10.1128/IAI.03004-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.

Authors:  Robert M Anthony; Joseph F Urban; Farhang Alem; Hossein A Hamed; Cristina T Rozo; Jean-Luc Boucher; Nico Van Rooijen; William C Gause
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

2.  Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Authors:  Daniel Elias; Sven Britton; Abraham Aseffa; Howard Engers; Hannah Akuffo
Journal:  Vaccine       Date:  2008-05-21       Impact factor: 3.641

Review 3.  Infections and allergy - helminths, hygiene and host immune regulation.

Authors:  Rick M Maizels
Journal:  Curr Opin Immunol       Date:  2005-09-30       Impact factor: 7.486

4.  Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection.

Authors:  J L Grogan; P G Kremsner; A M Deelder; M Yazdanbakhsh
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

5.  Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.

Authors:  D Elias; H Akuffo; C Thors; A Pawlowski; S Britton
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 6.  Chronic helminth infections protect against allergic diseases by active regulatory processes.

Authors:  Hermelijn H Smits; Bart Everts; Franca C Hartgers; Maria Yazdanbakhsh
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

7.  Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man.

Authors:  B M Greene; M M Fanning; J J Ellner
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.

Authors:  Kylie M Quinn; Fenella J Rich; Lisa M Goldsack; Geoffrey W de Lisle; Bryce M Buddle; Brett Delahunt; Joanna R Kirman
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

9.  Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection.

Authors:  Constance A M Finney; Matthew D Taylor; Mark S Wilson; Rick M Maizels
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

10.  Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogens.

Authors:  Hendrik J Nel; Nelita du Plessis; Leanie Kleynhans; André G Loxton; Paul D van Helden; Gerhard Walzl
Journal:  BMC Microbiol       Date:  2014-01-17       Impact factor: 3.605

View more
  10 in total

1.  Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis.

Authors:  Leticia Monin; Kristin L Griffiths; Wing Y Lam; Radha Gopal; Dongwan D Kang; Mushtaq Ahmed; Anuradha Rajamanickam; Alfredo Cruz-Lagunas; Joaquín Zúñiga; Subash Babu; Jay K Kolls; Makedonka Mitreva; Bruce A Rosa; Rosalio Ramos-Payan; Thomas E Morrison; Peter J Murray; Javier Rangel-Moreno; Edward J Pearce; Shabaana A Khader
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 2.  Helminth-Tuberculosis Co-infection: An Immunologic Perspective.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Trends Immunol       Date:  2016-08-05       Impact factor: 16.687

3.  Toxoplasma Co-infection Prevents Th2 Differentiation and Leads to a Helminth-Specific Th1 Response.

Authors:  Norus Ahmed; Timothy French; Sebastian Rausch; Anja Kühl; Katrin Hemminger; Ildiko R Dunay; Svenja Steinfelder; Susanne Hartmann
Journal:  Front Cell Infect Microbiol       Date:  2017-07-25       Impact factor: 5.293

Review 4.  A life without worms.

Authors:  Richard E Sanya; Gyaviira Nkurunungi; Irene Andia Biraro; Harriet Mpairwe; Alison M Elliott
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-01-01       Impact factor: 2.184

Review 5.  What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".

Authors:  Pere-Joan Cardona
Journal:  Front Immunol       Date:  2017-05-15       Impact factor: 7.561

6.  Species dependent impact of helminth-derived antigens on human macrophages infected with Mycobacterium tuberculosis: Direct effect on the innate anti-mycobacterial response.

Authors:  Naomi Aira; Anna-Maria Andersson; Susmita K Singh; Derek M McKay; Robert Blomgran
Journal:  PLoS Negl Trop Dis       Date:  2017-02-13

Review 7.  The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis.

Authors:  Agnes Natukunda; Ludoviko Zirimenya; Jacent Nassuuna; Gyaviira Nkurunungi; Stephen Cose; Alison M Elliott; Emily L Webb
Journal:  Parasite Immunol       Date:  2022-07-05       Impact factor: 2.206

8.  Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection.

Authors:  Erin Logan; Angelique Kany Kany Luabeya; Humphrey Mulenga; Dunja Mrdjen; Cynthia Ontong; Adam F Cunningham; Michele Tameris; Helen McShane; Thomas J Scriba; William G C Horsnell; Mark Hatherill
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

Review 9.  Helminth Infections Induce Tissue Tolerance Mitigating Immunopathology but Enhancing Microbial Pathogen Susceptibility.

Authors:  George S Yap; William C Gause
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

10.  Allergic Asthma Favors Brucella Growth in the Lungs of Infected Mice.

Authors:  Arnaud Machelart; Georges Potemberg; Laurye Van Maele; Aurore Demars; Maxime Lagneaux; Carl De Trez; Catherine Sabatel; Fabrice Bureau; Sofie De Prins; Pauline Percier; Olivier Denis; Fabienne Jurion; Marta Romano; Jean-Marie Vanderwinden; Jean-Jacques Letesson; Eric Muraille
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.